Pictet Asset Management (Switzerland)’s Pliant Therapeutics PLRX Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$11.6M	Buy	+639,808	New	+$15.1M	0.01%	592

Other funds holding PLRX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s PLRX Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) opened a new position in Pliant Therapeutics (PLRX) in Q2 2023: 639,808 shares worth $11.6M. The stake represents 0.01% of the portfolio and ranks #592 among its holdings.

144 funds tracked by Wall St. Rank hold PLRX as of Q2 2023.

Pictet Asset Management (Switzerland) held 639,808 shares of Pliant Therapeutics worth $11.6M as of Q2 2023.
Pliant Therapeutics was a new Pictet Asset Management (Switzerland) position in Q2 2023.
Pliant Therapeutics made up 0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #592 holding.
144 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.